PMS31 COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN BIOLOGIC-NAIVE PATIENTS FROM THE PORTUGUESE PERSPECTIVE

Autor: Laires, P., Silva, C., Esparteiro, J., Fonseca, J.E.
Zdroj: In Value in Health November 2019 22 Supplement 3:S699-S699
Databáze: ScienceDirect